Innovations, challenges and future prospects of oncoproteomics
- PMID: 19383334
- PMCID: PMC5527761
- DOI: 10.1016/j.molonc.2008.05.003
Innovations, challenges and future prospects of oncoproteomics
Abstract
Oncoproteomics is playing an increasingly important role in the diagnosis and management of cancer as well as in the development of personalized treatment of cancer. Innovative proteomic technologies relevant to cancer are described briefly, which are helping in the understanding of mechanism of drug resistance in cancer and will provide some leads to improve the management. Most important of these are nanoproteomics, i.e. application of nanobiotechnology to proteomics is playing an important role in nanooncology. Examples of some cancers will be given to point out the challenges and future prospects of oncoproteomics including those involving translation of technologies from the bench to the bedside.
Figures
References
-
- Cho, W.C. , Cheng, C.H. , 2007. Oncoproteomics: current trends and future perspectives. Expert Rev. Proteomics 4, 401–410. - PubMed
-
- D'Amico, T.A. , 2008. Molecular biologic staging of lung cancer. Ann. Thorac. Surg. 85, S737–S742. - PubMed
-
- Drev, P. , Grazio, S.F. , Bracko, M. , 2008. Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma. Appl. Immunohistochem. Mol. Morphol. 16, 179–184. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
